Study Stopped
COVID-19 Pandemic
Electrical Stimulation to Improve Recovery After Peripheral Nerve Injury
1 other identifier
interventional
7
1 country
1
Brief Summary
After nerve injury and facial palsy, many patients have permanent muscle and sensory dysfunction. Electrical stimulation (ES) of injured nerves may speed up axon growth and improve recovery. This study will assess if ES accelerates motor axon regeneration and improves muscle recovery in patients undergoing two-staged facial reanimation for facial palsy. This study of ES in these patients will investigate: i) nerve regeneration over long distances; ii) direct evidence of changes in nerve regeneration with nerve samples from the second procedure; and iii) changes in functional outcomes in a patient population with much less variability. Our study will provide evidence about the effect of ES in improving outcomes in patients with nerve injuries.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2019
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 20, 2019
CompletedFirst Posted
Study publicly available on registry
June 24, 2019
CompletedStudy Start
First participant enrolled
September 16, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 3, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
October 3, 2022
CompletedFebruary 13, 2023
February 1, 2023
3 years
June 20, 2019
February 9, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change in Pre-Operative Lip Excursion with Smile
FACEGRAM will be used to objectively analyse change in commissure excursion.
Change from Baseline (Pre-Op) over 2 Years
Change in Myelinated Axon Count
The number of myelinated nerve fibres that regenerate and reach the distal CFNG will be compared between groups.
Change from Baseline (Pre-Op) to the Final Surgery 1 Year Later
Secondary Outcomes (6)
Change in Facial Symmetry
Change from Baseline (Pre-Op) over 2 Years
Facial Clinimetric Evaluation (FaCE) Scores
Change from Baseline (Pre-Op) Over 2 Years
Time to Reinnervation
Up to 1 year after the Second Operation (FMT)
Myelin Thickness
Change from Baseline (Pre-Op) to the Final Surgery 1 Year Later
Nerve Fibre Diameter
Change from Baseline (Pre-Op) to the Final Surgery 1 Year Later
- +1 more secondary outcomes
Study Arms (2)
Electrical Stimulation
EXPERIMENTALElectrical Stimulation The patient will receive active electrical stimulation.
Sham Treatment
PLACEBO COMPARATORNo Electrical Stimulation The patient will receive sham electrical stimulation.
Interventions
Two-Stage Facial Reanimation (Standard Practice) with electrical stimulation for one hour at 20Hz (Experimental Procedure). 1. Cross-Facial Nerve Graft (CFNG) immediately followed by electrical nerve stimulation proximal to the coaptation site on the donor facial nerve. 2. Nine-to-Twelve Months later, Free Muscle Transfer (FMT) followed by electrical nerve stimulation proximal to the coaptation site in the intraoral incision.
Two-Stage Facial Reanimation (Standard Practice) with sham electrical stimulation for one hour (Placebo). 1. Cross-Facial Nerve Graft (CFNG) followed by placement of unelectrified electrodes proximal to the coaptation site on the donor facial nerve. 2. Free Muscle Transfer (FMT) followed by placement of unelectrified electrodes proximal to the coaptation site in the intraoral incision.
Eligibility Criteria
You may qualify if:
- Patients undergoing unilateral facial reanimation with a two-stage cross-face nerve graft and free gracilis muscle flap transfer who have;
- i) isolated unilateral facial nerve palsy and
- ii) a functioning contralateral facial nerve.
You may not qualify if:
- Any disorders that may compromise nerve regeneration or muscle function following muscle transfer, including diabetes, polyneuropathy, or myopathy and muscular dystrophy.
- Patients with severe cognitive impairment, which would limit their participation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Hospital for Sick Children
Toronto, Ontario, M5G 1X8, Canada
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kristen Davidge, MD
The Hospital for Sick Children
- PRINCIPAL INVESTIGATOR
Ronald Zuker, MD
The Hospital for Sick Children
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
June 20, 2019
First Posted
June 24, 2019
Study Start
September 16, 2019
Primary Completion
October 3, 2022
Study Completion
October 3, 2022
Last Updated
February 13, 2023
Record last verified: 2023-02